Premium
P2‐053: DESIGNING AND VALIDATION OF NOVEL THERAPEUTIC‐METHYLATED PEPTIDE INHIBITORS AS MULTITARGET DRUG FOR CANCER ASSOCIATED ALZHEIMER'S DISEASE
Author(s) -
Thangamani Lokesh,
Easwaran Murugesh,
Shanmughavel Piramanayagam,
Meyyazhagan Arun
Publication year - 2019
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2019.06.2460
Subject(s) - peptide , drug , cancer , function (biology) , computational biology , biology , in vivo , cancer research , pharmacology , biochemistry , microbiology and biotechnology , genetics